Testosterone Replacement Therapy Market Size, Top Emerging …

Apr 18, 2019 (Heraldkeeper via COMTEX) -- Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.

Request a sample Report of Testosterone Replacement Therapy Market at: https://www.marketstudyreport.com/request-a-sample/1583985?utm_source=MarketWatch&utm_medium=VS

The global average price of testosterone replacement therapy is in the decreasing trend, from 45.4 /Unit in 2012 to 34.9 /Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.

The Testosterone Replacement Therapy market stands tall as one of the most proactive industry verticals, as claimed by a new research report. This research study forecasts this space to accrue substantial proceeds by the end of the projected period, aided by a plethora of driving forces that will fuel the industry trends over the forecast duration. A gist of these driving factors, in tandem with myriad other dynamics pertaining to the Testosterone Replacement Therapy market, such as the risks that are prevalent across this industry as well as the growth opportunities existing in Testosterone Replacement Therapy market, have also been outlined in the report.

One of the most vital pointers that makes the Testosterone Replacement Therapy market report worth a purchase is the extensive overview of the competitive spectrum of the vertical. The study efficiently segregates the Testosterone Replacement Therapy market into AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin and Acerus Pharmaceuticals, as per the competitive hierarchy. In essence, these companies have been vying with one another to accrue a near-dominant position in the industry.

Ask for Discount on Testosterone Replacement Therapy Market Report at: https://www.marketstudyreport.com/check-for-discount/1583985?utm_source=MarketWatch&utm_medium=VS

The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 is about 72%.

Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy is sold in clinics, and the consumption proportion is about 43%.

North America region is the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe is the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.

North America is the largest consumption place, with a consumption market share nearly 83% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 12%.

Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan) Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The report supplies substantial data regarding the market share that every one of these companies currently garner across this business, in tandem with the market share that they are expected to procure by the end of the forecast period. Also, the report elaborates on details pertaining to the products manufactured by each of these firms, that would help new entrants and prominent stakeholders work on their competition and strategy portfolios. Not to mention, their decision-making process is liable to get easier on account of the fact that the Testosterone Replacement Therapy market report also enumerates a gist of the product price trends and the profit margins of each firm in the industry.

Important takeaways from the study:

Key questions answered in theTestosterone Replacement Therapy Marketreport:

For More Details On this Report:https://www.marketstudyreport.com/reports/global-testosterone-replacement-therapy-market-2019-by-manufacturers-regions-type-and-application-forecast-to-2024

Table of Contents

1 Market Overview 1.1 Testosterone Replacement Therapy Introduction 1.2 Market Analysis by Type 1.2.1 Gels 1.2.2 Injections 1.2.3 Patches 1.2.4 Other 1.3 Market Analysis by Applications 1.3.1 Hospitals 1.3.2 Clinics 1.3.3 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 AbbVie 2.1.1 Business Overview 2.1.2 Testosterone Replacement Therapy Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 AbbVie Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 Endo International 2.2.1 Business Overview 2.2.2 Testosterone Replacement Therapy Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Endo International Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 Eli lilly 2.3.1 Business Overview 2.3.2 Testosterone Replacement Therapy Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Eli lilly Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 Pfizer 2.4.1 Business Overview 2.4.2 Testosterone Replacement Therapy Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Pfizer Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.5 Actavis (Allergan) 2.5.1 Business Overview 2.5.2 Testosterone Replacement Therapy Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.6 Bayer 2.6.1 Business Overview 2.6.2 Testosterone Replacement Therapy Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Bayer Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.7 Novartis 2.7.1 Business Overview 2.7.2 Testosterone Replacement Therapy Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Novartis Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.8 Teva 2.8.1 Business Overview 2.8.2 Testosterone Replacement Therapy Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Teva Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.9 Mylan 2.9.1 Business Overview 2.9.2 Testosterone Replacement Therapy Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Mylan Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.10 Upsher-Smith 2.10.1 Business Overview 2.10.2 Testosterone Replacement Therapy Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.11 Ferring Pharmaceuticals 2.11.1 Business Overview 2.11.2 Testosterone Replacement Therapy Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.12 Kyowa Kirin 2.12.1 Business Overview 2.12.2 Testosterone Replacement Therapy Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.13 Acerus Pharmaceuticals 2.13.1 Business Overview 2.13.2 Testosterone Replacement Therapy Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Testosterone Replacement Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Testosterone Replacement Therapy Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Testosterone Replacement Therapy Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Testosterone Replacement Therapy Manufacturer Market Share in 2018 3.3.2 Top 6 Testosterone Replacement Therapy Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Testosterone Replacement Therapy Market Analysis by Regions 4.1 Global Testosterone Replacement Therapy Sales, Revenue and Market Share by Regions 4.1.1 Global Testosterone Replacement Therapy Sales and Market Share by Regions (2014-2019) 4.1.2 Global Testosterone Replacement Therapy Revenue and Market Share by Regions (2014-2019) 4.2 North America Testosterone Replacement Therapy Sales and Growth Rate (2014-2019) 4.3 Europe Testosterone Replacement Therapy Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Testosterone Replacement Therapy Sales and Growth Rate (2014-2019) 4.5 South America Testosterone Replacement Therapy Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Testosterone Replacement Therapy Sales and Growth Rate (2014-2019) 5 North America Testosterone Replacement Therapy by Country 5.1 North America Testosterone Replacement Therapy Sales, Revenue and Market Share by Country 5.1.1 North America Testosterone Replacement Therapy Sales and Market Share by Country (2014-2019) 5.1.2 North America Testosterone Replacement Therapy Revenue and Market Share by Country (2014-2019) 5.2 United States Testosterone Replacement Therapy Sales and Growth Rate (2014-2019) 5.3 Canada Testosterone Replacement Therapy Sales and Growth Rate (2014-2019) 5.4 Mexico Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)

Related Reports:

1. Global Medical Micro Injection Molding Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Micro injection molding is usually reserved for parts that weigh less than a milligram and are less than 1mm in length and is centered around medical and healthcare applications.

The classification of medical micro injection molding includes PE, PVC, PEEK and other materials, and the proportion of PE in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016. North America is the largest consumption place, with a consumption market share nearly 46% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 28%. Market competition is intense. SMC, BMP Medical, Stamm AG, MicroPEP, MTD Micro Molding, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Read More: https://www.marketstudyreport.com/reports/global-medical-micro-injection-molding-market-2019-by-company-regions-type-and-application-forecast-to-2024

2. Global Refurbished Medical Equipment Market 2019 by Company, Regions, Type and Application, Forecast to 2024 Refurbished Medical Equipment are fully tested, cleaned, calibrated and upgraded with new parts and renovation of older or damaged equipment to bring it to a workable or better looking condition and is free of defects. The remanufacturing of medical devices is a growing phenomenon within the health-care industry. The types of devices that are currently refurbished range from machines such as neonatal monitors and anesthesia vaporizers to devices used in surgery, such as forceps, endoscopes, and cytoscopes. Many firms are also restoring used disposable devices, such as catheters and surgical cutting instruments and accessories. Regardless of the product type, medical device remanufacturing carries an indisputable benefitreduced health-care costs.

Read More: https://www.marketstudyreport.com/reports/global-refurbished-medical-equipment-market-2019-by-company-regions-type-and-application-forecast-to-2024

Read More Reports On: https://www.marketwatch.com/press-release/Medical-Hair-Removal-Equipment-Market-Size-Top-Emerging-Trends-Growth-and-Business-Opportunities-Analysis-2024-2019-04-17

Contact Us: Corporate Sales, Market Study Report LLC Phone: 1-302-273-0910 Toll Free: 1-866-764-2150 Email: sales@marketstudyreport.com

View post:
Testosterone Replacement Therapy Market Size, Top Emerging ...

Testosterone Replacement Therapy Market to Expand at a Healthy 4.2% CAGR from 2016 to 2024 – Statsflash

The global testosterone replacement therapy market rides on the back of technology. As consumer focus shifts from access to comfort, players in the market for testosterone replacement therapy are looking at new opportunities to capitalize on the potential. This exclusive report from Transparency Market Research will take you through an extensive analysis of every aspect in the testosterone replacement therapy market that is critical for defining your success strategy. It offers prudent information on markets under currents, trends that will open new doors, factors that will remain important, challenges that need to be overcome, prevailing competition in the market, and the geographical landscape.

Based on a tested and proven research methodology, our research analysts bring to you fact-checked information. Besides presenting the current market figures, our analysts provide you with accurate forecasts that can be the game-changer for your winning strategies for tomorrow. On the other hand, our reports also offer tailor-made insights. Further, our reports are packed with experts viewpoints which are transcribed from interviews conducted by our analysts.

For Right Perspective & Competitive Insights, Request For A Sample Here

For every market, information on leading players can be the difference between success and failure, be it a prominent brand or not. Our reports cover every significant players in the global testosterone replacement therapy market providing information about the company profile, products, winning strategies and market revenues. Not just that, TMR also provides information on the competitive landscape, helping you understand what impacted in one company being the market leader and others not. It also explains on the companies imperatives that define their success in the global market for testosterone replacement therapy.

Healthcare, unlike most industries, is typical of the region. Humans have multiple races and hence their genetic makeups are different. As a result, one condition has different impacts depending on the region. Therefore, information on how consumer requirements are different in regional landscape of the global testosterone replacement therapy is provided her in the report. Further, the economic capabilities of a country has a huge impact on healthcare infrastructure. TMRs report analysis the current economic scenario and also brings to you information on affordability during the coming years.

To Clarify Your Doubts About The Report, Request A Brochure Here

From market share to region-specific strategies, the report covers it all. At the same time, players in the testosterone replacement therapy market who are looking to expand might want to assess the potential of a prospective region. Our reports can provide you with custom-made insights for specific regions in the global testosterone replacement therapy market. The geographical analysis also covers regions-specific factors that could turn out to be hurdle for growth in the coming years.

Visit link:
Testosterone Replacement Therapy Market to Expand at a Healthy 4.2% CAGR from 2016 to 2024 - Statsflash

Testosterone Side Effects in Detail – Drugs.com

For the Consumer

Applies to testosterone: buccal patch extended release

Along with its needed effects, testosterone may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking testosterone:

Get emergency help immediately if any of the following symptoms of overdose occur while taking testosterone:

Some side effects of testosterone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Applies to testosterone: buccal film extended release, compounding powder, intramuscular solution, nasal gel, subcutaneous implant, transdermal cream, transdermal film extended release, transdermal gel, transdermal ointment, transdermal solution

The most frequently reported side effects with this drug are edema, acne, site pain, injection site erythema, cough or dyspnea during or immediately after injection.

The most frequently reported side effects with testosterone topical are skin reaction (16.1%) and allergic contact dermatitis (up to 37%).[Ref]

Very common (10% or more): Testosterone topical: Skin reaction (16.1%), burn-like blisters (12%), itching, allergic contact dermatitis (up to 37%)Common (1% to 10%): Acne, induration, burningUncommon (0.1% to 1%): Alopecia, erythema, rash (including rash popular), pruritus, dry skin, folliculitis (testosterone topical)Frequency not reported: Seborrhea, urticaria, male pattern baldness, hirsutism injection site inflammationPostmarketing reports: Angioedema, angioneurotic edema, hyperhidrosis, discolored hair, leukocytoclastic vasculitis[Ref]

Very common (10% or more): Accelerated growthCommon (1% to 10%): Increased estradiol, hypogonadismUncommon (0.1% to 1%): Increased blood testosteroneFrequency not reported: Signs of virilization in women (e.g., hoarseness, acne, hirsutism, menstrual irregularity, clitoral enlargement, and alopecia), precocious puberty (in prepubertal males)Postmarketing reports: Hyperparathyroidism, prolactin increased, testosterone increased[Ref]

Very common (10% or more): Testosterone buccal film: Gingivitis (32.6%)Common (1% to 10%): Diarrhea, oily stools (due to IM injection oily solvent); Testosterone topical: Gastroesophageal reflux disease, gastrointestinal bleeding, gum or mouth irritation (9.2%), taste bitter, gum pain, gum tenderness, gum edema, taste perversionUncommon (0.1% to 1%): NauseaRare (less than 0.1%): Abdominal painFrequency not reported: Abdominal disorder, intraabdominal hemorrhagePostmarketing reports: Vomiting; Testosterone buccal film: Dry mouth, gingival swelling, lip swelling, mouth ulceration, stomatitis[Ref]

The majority of gum-related adverse events were transient.[Ref]

Very common (10% or more): Testosterone topical: Application site pruritus (up to 37%), application site blistering (12%)Common (1% to 10%): Injection site pain, injection site discomfort, injection site pruritus, erythema, injection site hematoma, injection site irritation, injection site inflammation; injection site reaction; Topical testosterone: Application site erythema, application site warmth, application site irritation, application site vesicles, application site exfoliation, application site burning, application site induration, bullae at application site, mechanical irritation at application site, rash at application site, contamination of application sitePostmarketing reports: Injection site abscess, procedural pain, application site swelling (topical testosterone)[Ref]

Common (1% to 10%): Hot flush, hypertensionUncommon (0.1% to 1%): Cardiovascular disorderFrequency not reported: Venous thromboembolismPostmarketing reports: Angina pectoris, cardiac arrest, cardiac failure, coronary artery disease, coronary artery occlusion, myocardial infarction, tachycardia, cerebral infarction, cerebrovascular accident, circulatory collapse, deep venous thrombosis, syncope, thromboembolism, thrombosis, venous insufficiency, stroke[Ref]

Common (1% to 10%): Abnormal prostate examination, benign prostate hyperplasia (BPH), ejaculation disorder, prostatitisUncommon (0.1% to 1%): Prostate induration, prostatic disorder, testicular pain, decreased urine flow, urinary retention, urinary tract disorder, nocturia, dysuriaRare (less than 0.1%): Micturition disorders, epididymitis, bladder irritability, impotence, inhibition of testicular function and testicular atrophyFrequency not reported: Oligospermia, priapism, benign prostatic hyperplasia (prostatic growth to eugonadal state), excessive frequency and duration of erections; Pediatrics: Precocious sexual development, an increased frequency of erections, phallic enlargementPostmarketing reports: Prostate infection, calculus urinary, dysuria, hematuria, urinary tract disorder, pollakiuria[Ref]

Common (1% to 10%): Polycythemia, hematocrit increasedUncommon (0.1% to 1%): Increased red blood cell count, increased hemoglobin, prolonged activated partial thromboplastin time, prolonged prothrombin timeFrequency not reported: Blood and lymphatic system disorders, suppression of clotting factors II, V, VII, and X, bleeding in patients on concomitant anticoagulant therapyPostmarketing reports: Thrombocytopenia, anemia[Ref]

Common (1% to 10%): Weight increased, appetite increased, fluid retention (sodium, chloride, water, potassium, calcium, and inorganic phosphates)Uncommon (0.1% to 1%): Increased glycosylated hemoglobin, hypercholesterolemia, increased triglycerideFrequency not reported: Abnormal lipids (decrease in serum LDL, HDL, and triglycerides), metabolism and nutrition disorders, hypercalcemiaPostmarketing reports: Hypoglycemia, diabetes mellitus, fluid retention, hyperlipidemia, hypertriglyceridemia, blood glucose increased[Ref]

Common (1% to 10%): Back pain, hemarthrosis (testosterone topical)Uncommon (0.1% to 1%): Arthralgia, pain in extremity, muscle spasm, muscle strain, myalgia, musculoskeletal stiffness, increased creatine phosphokinaseFrequency not reported: Pediatrics: Premature epiphyseal closure, increased bone formationPostmarketing reports: Musculoskeletal chest pain, musculoskeletal pain, myalgia, osteopenia, osteoporosis, systemic lupus erythematosus[Ref]

Common (1% to 10%): Headache, vertigo (topical testosterone)Uncommon (0.1% to 1%): Migraine, tremor, dizzinessFrequency not reported: Nervousness, paresthesiaPostmarketing reports: Cerebrovascular insufficiency, reversible ischemic neurological deficiency, transient ischemic attack, amnesia[Ref]

Common (1% to 10%): Prostatic specific antigen (PSA) increased, prostate cancerUncommon (0.1% to 1%): Prostatic intraepithelial neoplasiaRare (less than 0.1%): Neoplasms benign, malignant, and unspecified (including cysts and polyps)[Ref]

Common (1% to 10%): Fatigue, hyperhidrosis; chills, body pain, smell disorderUncommon (0.1% to 1%): Breast induration, breast pain, sensitive nipples, gynecomastia, increased estradiol, increased testosterone, asthenia, night sweats Rare (less than 0.1%): Fever, malaiseFrequency not reported: EdemaPostmarketing reports: Sudden hearing loss, tinnitus, Influenza like illness[Ref]

Common (1% to 10%): Irritability, insomnia, mood swings, aggression,Uncommon (0.1% to 1%): Depression, emotional disorder, restlessness, increased libido, decreased libidoFrequency not reported: Hostility, anxietyPostmarketing reports: Korsakoff's psychosis nonalcoholic, male orgasmic disorder, restlessness, sleep disorder[Ref]

Common (1% to 10%): Sinusitis, nasopharyngitis, upper respiratory tract infection, bronchitisUncommon (0.1% to 1%): Cough, dyspnea, snoring, dysphoniaRare (less than 0.1%): Pulmonary microembolism (POME) (cough, dyspnea, malaise, hyperhidrosis, chest pain, dizziness, paresthesia, or syncope) caused by oily solutionsFrequency not reported: Sleep apneaPostmarketing reports: Chest pain, asthma, chronic obstructive pulmonary disease, hyperventilation, obstructive airway disorder, pharyngeal edema, pharyngolaryngeal pain, pulmonary embolism, respiratory distress, rhinitis, sleep apnea syndrome[Ref]

Signs and symptoms of pulmonary microemboli may occur during or immediately after the injections and are reversible.[Ref]

Uncommon (0.1% to 1%): Abnormal LFT, increased ASTRare (less than 0.1%): Abnormal hepatic functionFrequency not reported: Jaundice, benign liver tumor, malignant liver tumor, liver enlargement, peliosis hepatitisPostmarketing reports: ALT increased, AST increased, bilirubin increased, transaminases increased, gamma-glutamyltransferase increased[Ref]

Uncommon (0.1% to 1%): Hypersensitivity reactionsFrequency not reported: Anaphylactic reactionsPostmarketing reports: Anaphylactic shock[Ref]

Uncommon (0.1% to 1%): Testosterone topical: Lacrimation increasedPostmarketing reports: Testosterone topical: Intraocular pressure increased, vitreous detachment[Ref]

Postmarketing reports: Nephrolithiasis, renal colic, renal pain[Ref]

1. "Product Information. Fortesta (testosterone)." Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.

2. "Product Information. AndroGel (testosterone)." Unimed Pharmaceuticals, Buffalo Grove, IL.

3. Cerner Multum, Inc. "Australian Product Information." O 0

4. "Product Information. Testosterone Enanthate (testosterone)." West-Ward Pharmaceutical Corporation, Eatontown, NJ.

5. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

6. "Product Information. Axiron (testosterone)." Lilly, Eli and Company, Indianapolis, IN.

7. "Product Information. Testopel (testosterone)." Bartor Pharmacal Co, Inc, Rye, NY.

8. "Product Information. Aveed (testosterone)." Endo Pharmaceuticals Solutions Inc, Malvern, PA.

9. "Product Information. Testim (testosterone)." A-S Medication Solutions, Chicago, IL.

10. "Product Information. Androderm (testosterone topical)." SmithKline Beecham, Philadelphia, PA.

11. "Product Information. Depo-Testosterone (testosterone)." Pfizer U.S. Pharmaceuticals Group, New York, NY.

12. Bates GW, Cornwell CE "Iatrogenic causes of hirsutism." Clin Obstet Gynecol 34 (1991): 848-51

13. Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA "Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men." J Clin Endocrinol Metab 84 (1999): 3469-78

14. O'Driscoll JB, August PJ "Exacerbation of psoriasis precipitated by an oestradiol-testosterone implant." Clin Exp Dermatol 15 (1990): 68-9

15. Fyrand O, Fiskaadal HJ, Trygstad O "Acne in pubertal boys undergoing treatment with androgens." Acta Derm Venereol 72 (1992): 148-9

16. Traupe H, von Muhlendahl KE, Bramswig J, Happle R "Acne of the fulminans type following testosterone therapy in three excessively tall boys." Arch Dermatol 124 (1988): 414-7

17. Wu FC, Farley TM, Peregoudov A, Waites GM "Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organizatio Task Force on Methods for the Regulation of Male Fertility." Fertil Steril 65 (1996): 626-36

18. Bennett NJ "A burn-like lesion caused by a testosterone transdermal system." Burns 24 (1998): 478-80

19. Buckley DA, Wilkinson SM, Higgins EM "Contact allergy to a testosterone patch." Contact Dermatitis 39 (1998): 91-2

20. DeSanctis V, Vullo C, Urso L, Rigolin F, Cavallini A, Caramelli K, Daugherty C, Mazer N "Clinical experience using the Androderm (R) testosterone transdermal system in hypogonadal adolescents and young men with beta-thalassemia major." J Pediatr Endocrinol Metab 11 (1998): 891-900

21. Cefalu WT, Pardridge WM, Premachandra BN "Hepatic bioavailability of thyroxine and testosterone in familial dysalbuminemic hyperthyroxinemia." J Clin Endocrinol Metab 61 (1985): 783-6

22. Matsumoto AM "Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production." J Clin Endocrinol Metab 70 (1990): 282-7

23. Tripathy D, Shah P, Lakshmy R, Reddy KS "Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathi hypogonadotrophic hypogonadism." Horm Metab Res 30 (1998): 642-5

24. Becker U, Gluud C, Bennett P "The effect of oral testosterone on serum TBG levels in alcoholic cirrhotic men." Liver 8 (1988): 219-24

25. Ferrera PC, Putnam DL, Verdile VP "Anabolic steroid use as the possible precipitant of dilated cardiomyopathy." Cardiology 88 (1997): 218-20

26. Jackson JA, Waxman J, Spiekerman AM "Prostatic complications of testosterone replacement therapy." Arch Intern Med 149 (1989): 2365-6

27. Zelissen PM, Stricker BH "Severe priapism as a complication of testosterone substitution therapy." Am J Med 85 (1988): 273-4

28. Wang C, Leung A, Superlano L, Steiner B, Swerdloff RS "Oligozoospermia induced by exogenous testosterone is associated with normal functioning residual spermatozoa." Fertil Steril 68 (1997): 149-53

29. Endres W, Shin YS, Rieth M, Block T, Schmiedt E, Knorr D "Priapism in Fabry's disease during testosterone treatment." Klin Wochenschr 65 (1987): 925

30. Parker LU, Bergfeld WF "Virilization secondary to topical testosterone." Cleve Clin J Med 58 (1991): 43-6

31. Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ "A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men." J Clin Endocrinol Metab 84 (1999): 3642-7

32. Anderson FH, Francis RM, Faulkner K "Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascula risk factors." Bone 18 (1996): 171-7

33. Bhasin S, Storer TW, Javanbakht M, et al. "Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels." JAMA 283 (2000): 763-70

34. Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE, Bremner WJ "Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men." J Clin Endocrinol Metab 79 (1994): 561-7

35. Lajarin F, Zaragoza R, Tovar I, Martinezhernandez P "Evolution of serum lipids in two male bodybuilders using anabolic steroids." Clin Chem 42 (1996): 970-2

36. Zmuda JM, Thompson PD, Dickenson R, Bausserman LL "Testosterone decreases lipoprotein(a) in men." Am J Cardiol 77 (1996): 1244

37. Stannard JP, Bucknell AL "Rupture of the triceps tendon associated with steroid injections." Am J Sports Med 21 (1993): 482-5

38. Pollard M "Tumorigenic effect of testosterone." Lancet 336 (1990): 1518

39. Uzych L "Anabolic-androgenic steroids and psychiatric-related effects: a review." Can J Psychiatry 37 (1992): 23-8

40. Nuzzo JL, Manz HJ, Maxted WC "Peliosis hepatis after long-term androgen therapy." Urology 25 (1985): 518-9

41. Carrasco D, Prieto M, Pallardo L, Moll JL, Cruz JM, Munoz C, Berenguer J "Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature." J Hepatol 1 (1985): 573-8

42. Yu MW, Chen CJ "Elevated serum testosterone levels and risk of hepatocellular carcinoma." Cancer Res 53 (1993): 790-4

43. Falk H, Thomas LB, Popper H, Ishak KG "Hepatic angiosarcoma associated with androgenic-anabolic steroids." Lancet 2 (1979): 1120-3

Some side effects of testosterone may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Read the original:
Testosterone Side Effects in Detail - Drugs.com

Testosterone Replacement Therapy Cost – tctmed.com

Low T Treatment, also known as Testosterone replacement therapy or TRT, has become a much more common treatment for both men and women in recent years.

Because of this, options for treatment of Low T have also grown, but what can one expect testosterone replacement therapy to cost?

Most of the testosterone replacement therapy cost is covered by insurance, and affordable cash plans are also available.

Your choices are numerous, and Low T clinics and centers seem to be everywhere.

However, not all treatments and clinics are created equal. When we say that we are Setting the Standard, we are stating that we are committed to giving you the highest quality of care.

This goes beyond the standard testosterone replacement therapy cost beyond the mere dollar amount. The value of that is substantial, and it is something you will see once you meet with our dedicated providers.

At Testosterone Centers of Texas we will always work hard to provide superior service that places solid patient care atop a long list of priorities that keep our standards high.

With TCT, you receive personalized care that improves your quality of life without sacrificing your overall healthand you receive all of this in an efficient and streamlined manner.

We believe that men and women who suffer from the symptoms of Low T should expect a high level of care and expertise alongside affordability of treatment.

Consultations for prospective patients are free!

You can call or come by at any time to speak with one of our knowledgeable providers about your symptoms and whether or not TRT might be right for youjust click here to set up a free consultation.

To make sure that men and women who need treatment can get treatmentand not avoid contacting us because of a potentially high testosterone replacement therapy cost we do accept insurance, and we also have an affordable cash plan.

If you expect testosterone replacement therapy to cost a lot, you might be in for a surprise.

For insured patients, your benefits can be verified before your first visit and your pricing will be dependent upon your individual plan.

For those patients paying out-of-pocket, we offer an initialevaluation of total and free testosterone for just $25.

If you decide that the testosterone replacement therapy cost is outweighed by all the benefits of feeling like yourself again, and you want to proceed with treatment, the cost of the initial evaluation is applied to the month-to-month cash fee of $299/month, and this pricing covers visits, injections, and in-house labs.

Contact us today to schedule your free consultation!

Read the original:
Testosterone Replacement Therapy Cost - tctmed.com

Is Testosterone Replacement Therapy Safe for My Prostate? – Video


Is Testosterone Replacement Therapy Safe for My Prostate?
Testosterone replacement therapy, or TRT, is becoming increasingly popular for men who are entering middle age. As men age, their testosterone declines. This process is increased by lack...

By: Prostate Cancer Live

Read the original:
Is Testosterone Replacement Therapy Safe for My Prostate? - Video

testosterone replacement therapy options | Find a testosterone replacement therapy options – Video


testosterone replacement therapy options | Find a testosterone replacement therapy options
testosterone replacement therapy options | Find a testosterone replacement therapy options Testosterone Replacement Therapy -- Do you really need This? Like a lady age groups, this is a provided...

By: testosterone replacement therapy options

Read this article:
testosterone replacement therapy options | Find a testosterone replacement therapy options - Video

Doc Won’t Put Me On Testosterone Replacement Therapy! SHOULD I TREAT MYSELF ILLEGALY?| Ask Noah #1 – Video


Doc Won #39;t Put Me On Testosterone Replacement Therapy! SHOULD I TREAT MYSELF ILLEGALY?| Ask Noah #1
A new segment on this channel where I answer a viewers question on video detailing their specific situation. Put #asknoah at the beginning of any message you...

By: bignoknow

See original here:
Doc Won't Put Me On Testosterone Replacement Therapy! SHOULD I TREAT MYSELF ILLEGALY?| Ask Noah #1 - Video

Testosterone Replacement Therapy San Diego | Total T Clinic | 858-519-5509 – Video


Testosterone Replacement Therapy San Diego | Total T Clinic | 858-519-5509
Total T Clinic https://plus.google.com/113080934464818265745/about Low T, or low testosterone levels affect thousands of men like you living in San Diego. An optimal balance of hormones is...

By: Total T Clinic

More here:
Testosterone Replacement Therapy San Diego | Total T Clinic | 858-519-5509 - Video

Testosterone Replacement Therapy Market Analysis by Size, Share, Top Key Manufacturers, Demand Overview, Regional Outlook And Growth Forecast to 2026…

Acerus Pharmaceuticals

Global Testosterone Replacement Therapy Market Segmentation

This market was divided into types, applications and regions. The growth of each segment provides an accurate calculation and forecast of sales by type and application in terms of volume and value for the period between 2020 and 2026. This analysis can help you develop your business by targeting niche markets. Market share data are available at global and regional levels. The regions covered by the report are North America, Europe, the Asia-Pacific region, the Middle East, and Africa and Latin America. Research analysts understand the competitive forces and provide competitive analysis for each competitor separately.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=208345&utm_source=COD&utm_medium=888

Global Testosterone Replacement Therapy Market Regions and Countries Level Analysis

The regional analysis is a very complete part of this report. This segmentation highlights Testosterone Replacement Therapy sales at regional and national levels. This data provides a detailed and accurate analysis of volume by country and an analysis of market size by region of the world market.

The report provides an in-depth assessment of growth and other aspects of the market in key countries such as the United States, Canada, Mexico, Germany, France, the United Kingdom, Russia and the United States Italy, China, Japan, South Korea, India, Australia, Brazil and Saudi Arabia. The chapter on the competitive landscape of the global market report contains important information on market participants such as business overview, total sales (financial data), market potential, global presence, Testosterone Replacement Therapy sales and earnings, market share, prices, production locations and facilities, products offered and applied strategies. This study provides Testosterone Replacement Therapy sales, revenue, and market share for each player covered in this report for a period between 2016 and 2020.

Why choose us:

We offer state of the art critical reports with accurate information about the future of the market.

Our reports have been evaluated by some industry experts in the market, which makes them beneficial for the company to maximize their return on investment.

We provide a full graphical representation of information, strategic recommendations and analysis tool results to provide a sophisticated landscape and highlight key market players. This detailed market assessment will help the company increase its efficiency.

The dynamics of supply and demand shown in the report offer a 360-degree view of the market.

Our report helps readers decipher the current and future constraints of the Testosterone Replacement Therapy market and formulate optimal business strategies to maximize market growth.

Have Any Query? Ask Our Expert @ https://www.marketresearchintellect.com/need-customization/?rid=208345&utm_source=COD&utm_medium=888

Table of Contents:

Study Coverage: It includes study objectives, years considered for the research study, growth rate and Testosterone Replacement Therapy market size of type and application segments, key manufacturers covered, product scope, and highlights of segmental analysis.

Executive Summary: In this section, the report focuses on analysis of macroscopic indicators, market issues, drivers, and trends, competitive landscape, CAGR of the global Testosterone Replacement Therapy market, and global production. Under the global production chapter, the authors of the report have included market pricing and trends, global capacity, global production, and global revenue forecasts.

Testosterone Replacement Therapy Market Size by Manufacturer: Here, the report concentrates on revenue and production shares of manufacturers for all the years of the forecast period. It also focuses on price by manufacturer and expansion plans and mergers and acquisitions of companies.

Production by Region: It shows how the revenue and production in the global market are distributed among different regions. Each regional market is extensively studied here on the basis of import and export, key players, revenue, and production.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Testosterone Replacement Therapy Market Size, Testosterone Replacement Therapy Market Growth, Testosterone Replacement Therapy Market Forecast, Testosterone Replacement Therapy Market Analysis

Follow this link:
Testosterone Replacement Therapy Market Analysis by Size, Share, Top Key Manufacturers, Demand Overview, Regional Outlook And Growth Forecast to 2026...

Testosterone Replacement Theraphy – Testicular Cancer Canada Patient Symposium 2014 – Video


Testosterone Replacement Theraphy - Testicular Cancer Canada Patient Symposium 2014
Testosterone Replacement Therapy by Dean Elterman, MD, FRCSC University of Toronto, University Health Network.

By: Testicular Cancer Canada

Follow this link:

Testosterone Replacement Theraphy - Testicular Cancer Canada Patient Symposium 2014 - Video

How To Survive Low Testosterone Or A TRT Crash (Testosterone Replacement Therapy) – Video


How To Survive Low Testosterone Or A TRT Crash (Testosterone Replacement Therapy)
If you are expecting or experiencing low testosterone or going through a TRT (Testosterone Replacement Therapy) Crash, then this video will help you to prepa...

By: Paolo Broccardo

Read the original post:
How To Survive Low Testosterone Or A TRT Crash (Testosterone Replacement Therapy) - Video

Testosterone Replacement Therapy: Controversy and Trends – Medscape

Abstract and Introduction Abstract

In recent years, testosterone replacement therapy (TRT) has received significant media attention, and the rate of testosterone use has increased notably. A reported association between testosterone use and increased occurrence of myocardial infarction and stroke prompted the FDA to issue a safety bulletin in 2014. Clinical hypogonadism is the only FDA-approved indication for TRT in men; it is not approved to treat age-related low testosterone. Although it is not indicated, TRT is often recommended to improve sexual function, bone density, body composition, muscle strength, mood, behavior, and cognition. The literature on the effectiveness of TRT for various conditions is largely mixed; therefore, current data on appropriate and potentially inappropriate use are important for pharmacists to keep abreast of and discuss with patients.

Recently, the use of testosterone replacement therapy (TRT) has received a lot of media attention. Although its use is growing, there is much debate regarding TRT's risks and benefits.[1] From 2008 to 2012 in the United States, spending on TRT increased from $1 billion to $2 billion, and from 2003 to 2013 there was a fourfold increase in the rate of TRT in men aged 18 to 45 years.[2] In 2013 and early 2014, two studies reported an association between TRT and increased occurrence of myocardial infarction and stroke, prompting the FDA to issue a safety bulletin on January 31, 2014.[3] This article will discuss appropriate TRT use, available formulations and cost, side effects, trends, and the pharmacist's role in patient education, including counseling points.

Link:
Testosterone Replacement Therapy: Controversy and Trends - Medscape